Answers are grounded in this paper and cite their sources.
Background: Since the introduction of Highly Active Antiretroviral Therapy (HAART), human immunodeficiency virus (HIV) infection has transitioned from a fatal to a manageable chronic condition. However, long-term exposure to first-generation nucleoside reverse transcriptase inhibitors (NRTIs), including zidovudine, stavudine, didanosine, and zalcitabine, is associated with significant mitochondrial toxicity. Mitochondria-dependent muscles, such as the levator palpebrae superioris, may be particularly vulnerable. Case reports have suggested a link between NRTI exposure and ptosis, but this relationship has not been the subject of a detailed systematic evaluation. Objective: This study investigated ptosis as a potential clinical marker of acquired mitochondrial dysfunction in patients with long-term HIV exposure to NRTIs and evaluated surgical outcomes. Methods: This monocentric retrospective study included 63 HIV-infected patients (109 eyelids) treated for ptosis between 2012 and 2024 at the Fondation Adolphe de Rothschild Hospital. Clinical and surgical data were extracted, including levator function, palpebral fissure height, margin reflex distance 1, ophthalmological findings (diplopia, ophthalmoplegia, and pigmentary retinopathy), neurological comorbidities, and HIV treatment history. Levator muscle biopsies were performed during surgery when indicated, with subsequent histological and molecular analyses to assess the mitochondrial pathology. Patients were grouped based on levator function, and the association between cumulative duration of antiretroviral therapy and neurological/ophthalmological findings was assessed using a data-driven cutoff analysis scanning all possible duration thresholds. Results: The cohort had a mean age of 68.3 years; 76% underwent ptosis surgery, most commonly anterior levator resection (79%). Most patients (67%) were diagnosed with HIV infection before 2000, with a mean treatment duration of 32.5 years. Levator function was limited (<8 mm) in 18% of cases. Diplopia or ophthalmoplegia and pigmentary retinopathy occurred in 32% and 13% of the eyelids, respectively. These manifestations were strongly associated with limited levator function (diplopia, 80% vs. 21%, p < 0.001; retinopathy, 50% vs. 4.5%, p < 0.001). Mixed axonal neuropathy and encephalopathy were also significantly more common in the limited function group. No significant association was found between cumulative antiretroviral therapy duration and any neurological or ophthalmological finding, including after testing all possible duration cutoffs. The overall surgical revision rate was 17%, which was higher in the patients with limited levator function (27.8%) and pigmentary retinopathy (40%). Only one muscle biopsy revealed mitochondrial myopathy (ragged-red fibers and cytochrome c oxidase-negative fibers). Genetic analysis of this patient showed focal deletions, supporting an acquired toxic origin. Discussion: This study represents the largest reported series investigating ptosis in patients with HIV and its potential mitochondrial origin. The data support a strong correlation between limited levator function and ophthalmoneurological findings, consistent with mitochondrial dysfunction. The absence of large-scale mitochondrial DNA deletions and the late onset of symptoms argue against congenital syndromes, favoring a model of NRTI-induced acquired mitochondriopathy. The observed phenotype aligns with a Kearns–Sayre syndrome-like presentation. These findings suggest parallel conditions, such as myasthenia gravis, in which ptosis may constitute an early manifestation of broader disease involvement. While the use of first-generation NRTIs has declined in high-resource settings, continued vigilance is warranted in low-resource countries, where these agents remain in circulation. Conclusion: Ptosis may serve as an early and accessible clinical marker for antiretroviral-induced mitochondrial toxicity. Our findings reinforce the importance of long-term vigilance for neuromuscular signs in patients with HIV, especially those exposed to early-generation NRTIs. Future multicenter studies are needed to confirm these observations and refine diagnostic and surgical strategies.
No takes yet. Share an insight, caveat, or question.
Matagrin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: